The Lead Episode 10: A Discussion of Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial

Discussion Topic: Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial by Atul Verma et al.

William H. Sauer, MD, FHRS, CCDS, is joined by guests Nathaniel Steiger, MD, and Paul C. Zei, MD, PhD, FHRS, for a discussion on the PULSED AF Pivotal Trial. This was a prospective, global, multicenter, nonrandomized, paired single-arm study in which patients with paroxysmal (n=150) or persistent (n=150) symptomatic atrial fibrillation (AF) refractory to class I or III antiarrhythmic drugs were treated with pulsed field ablation. The results demonstrate similar efficacy compared with clinical studies evaluating radiofrequency ablation and cryothermal ablation. Safety with the new form of ablation technology appeared to be promising with no evidence of esophageal injury or phrenic nerve palsy observed.

Host: William H. Sauer, MD, FHRS, CCDS
Guests: Nathaniel Steiger, MD and Paul C. Zei, MD, PhD, FHRS

Speaker and Article Information: Download

• Listen on HRS365
• Listen on Apple Podcasts
• Listen on Spotify